Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: JACC Clin Electrophysiol. 2023 Nov 22;10(2):346–355. doi: 10.1016/j.jacep.2023.10.015

TABLE 3.

Effect of Treatment on Autonomic Symptoms

Baseline
 2 mo
Sham (n = 14) Active (n = 12) P Value Sham (n = 14) Active (n = 11) P Value
Total 48.9 ± 9.5 48.8 ± 8.6 0.95 47.3 ± 8.2 42.6 ± 6.3 0.07
Orthostatic intolerance 25.9 ± 4.2 26.1 ± 4.5 0.92 23.9 ± 4.6 23.1 ± 5.0 0.60
Vasomotor function 2.7 ± 1.2 2.5 ± 1.4 0.97 2.8 ± 1.0 2.7 ± 0.7 0.50
Secretomotor function 5.8 ± 3.6 5.6 ± 3.5 0.82 6.1 ± 3.7 2.9 ± 3.3 0.001
Gastrointestinal function 10.3 ± 4.6 10.2 ± 3.5 0.94 10.3 ± 4.7 9.8 ± 3.9 0.59
Bladder function 1.6 ± 1.8 1.9 ± 1.4 0.84 1.6 ± 1.7 1.7 ± 1.4 0.69
Pupillomotor function 2.5 ± 1.1 2.5 ± 0.8 0.94 2.5 ± 1.2 2.5 ± 1.2 0.97

Values are mean ± SD.